InhalerClinical Overview
Formoterol Fumarate (6mcg) and Fluticasone Propionate (250mcg Inhaler / Powder for Inhalation) combines a rapid-onset, long-acting beta-2 agonist with a high-affinity synthetic fluorinated corticosteroid. Delivers fast bronchodilation within minutes along with comprehensive mucosal anti-inflammatory suppression. Indicated for regular maintenance treatment of persistent asthma in patients not adequately controlled on inhaled corticosteroids alone.
Active Pharmaceutical Ingredients
Verified Clinical References
Usage Guidelines
Inhale 1 to 2 puffs twice daily (morning and evening) with a full rinse and spit of water afterward. Do not exceed prescribed frequency.
General Administration Advice: Adhere strictly to the prescribed dosage, frequency, and treatment course. For oral medications, swallow with sufficient water. Never stop antibiotics, psychiatric medications, or antihypertensives abruptly without clinical direction.
Possible Side Effects
Common: Oral thrush, voice hoarseness, headache, tremor, palpitations. Rare/Severe: Paradoxical bronchospasm, hypokalemia, and severe allergic reactions.
*Note: Individual physiological responses vary. While many patients experience few or no side effects, notify your treating physician if adverse reactions persist or if hypersensitivity (angioedema, skin rash, dyspnea) occurs.
Precautions & Warnings
Rinse mouth thoroughly with water after each use. Not intended for relief of sudden acute asthma attacks unless part of an approved MART protocol.
Medical Disclaimer: Statutory Clinical Disclaimer: The information provided is for educational and price-transparency purposes only and does not constitute medical advice, pulmonological diagnosis, or respiratory management recommendations. Inhalation therapies and allergy medications should be used strictly under the guidance of a qualified pulmonologist or registered medical practitioner.
Formoterol 6mcg + Budesonide 200mcg Rotacaps
Formoterol Fumarate (6mcg/12mcg) and Budesonide (100mcg/200mcg/400mcg Inhaler, Rotacaps, Powder, or Nebuliser Suspension) is a gold-standard fixed-dose combination on the WHO Model List of Essential Medicines. Budesonide is a potent inhaled glucocorticoid that suppresses airway mucosal inflammation, reduces microvascular permeability, and decreases hyperresponsiveness. Formoterol is a rapid-onset, long-acting beta-2 adrenergic agonist (LABA) that stimulates adenylyl cyclase, relaxes bronchial smooth muscle within 1-3 minutes, and provides sustained bronchodilation for >12 hours. Recommended by GINA guidelines as preferred Maintenance and Reliever Therapy (SMART / MART). Indicated for maintenance and rescue relief of bronchial asthma and symptomatic maintenance of Chronic Obstructive Pulmonary Disease (COPD).
Salmeterol 50mcg + Fluticasone 250mcg Rotacaps
Salmeterol Xinafoate (25mcg/50mcg) and Fluticasone Propionate (100mcg/250mcg/500mcg Inhaler, Rotacaps) is a benchmark inhaled corticosteroid and long-acting beta-2 agonist combination on the WHO Model List of Essential Medicines. Fluticasone exerts profound local anti-inflammatory, immunosuppressive, and anti-edematous effects in bronchial mucosa with low systemic bioavailability due to extensive first-pass metabolism. Salmeterol provides long-acting bronchodilation lasting over 12 hours via persistent beta-2 receptor activation. Indicated for maintenance therapy of persistent bronchial asthma and maintenance treatment of airflow obstruction in patients with severe COPD and recurrent exacerbations.
Fluticasone Propionate Respules 0.5mg per 2ml
Fluticasone Propionate Respules (0.5mg per 2ml) is an inhaled corticosteroid nebulizer suspension on the WHO Model List framework. Delivers high topical anti-inflammatory potency to bronchial mucosal tissues. Indicated for maintenance management of severe persistent asthma and acute exacerbations in pediatric and adult patients unable to coordinate inhaler devices.
Azelastine Hydrochloride 140mcg + Fluticasone Propionate 50mcg Nasal Spray
Azelastine Hydrochloride (140mcg) and Fluticasone Propionate (50mcg) Nasal Spray is a fixed-dose second-generation H1-antihistamine and corticosteroid combination on the WHO Model List framework. Azelastine provides rapid-onset (within 15 minutes) blockade of histamine H1 receptors, relieving sneezing, nasal itching, and rhinorrhea. Fluticasone provides sustained 24-hour suppression of mucosal inflammation, relieving stubborn nasal congestion. Proven significantly superior to either monotherapy for Moderate-to-Severe Allergic Rhinitis and seasonal rhinoconjunctivitis.